Inogen (INGN)
(Delayed Data from NSDQ)
$9.01 USD
+0.01 (0.11%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $8.99 -0.02 (-0.22%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
INGN 9.01 +0.01(0.11%)
Will INGN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for INGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for INGN
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Asensus Surgical (ASXC) Inks a Merger Agreement With KARL STORZ
INGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inogen (INGN) Down 0.1% Since Last Earnings Report: Can It Rebound?
Should You Buy Canopy Growth (CGC) Ahead of Q4 Earnings?
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
Other News for INGN
Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development
Inogen Annual Meeting: Strategic Direction and Governance Outcomes
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
Inogen publishes study linking portable oxygen concentrators, higher survival
Inogen Announces Executive Leadership Restructuring